tivozanib
jazz,kyowa kirin,aveo oncology
['tivozanib']
aveo oncology presents three posters for tivozanib at the 2022 asco annual meeting - long-term os analyses of tivo-3 continue to trend in favor of tivozanib, patients with pfs at 1 year demonstrated a 55% reduction in risk of death on tivozanib as compa... 
CEO Of Digital Media Online